Prospective multicentre study of experience in real-world clinical practice in monitoring reported outcome measures (PROMs) of patient with a diagnosis of psoriatic and/or spondyloarthritis and initiating treatment with secukinumab Juan José Lerma Garrido; Antonio Gracia Pérez; Antonio Pérez Torres; Amalia Rueda Cid; Clara Molina Almela; María Dolores Pastor Cubillo; Cristina Campos Fernández; Isabel Balaguer Trull; Loreto Carmona; Javier Calvo Catalá;

The impact of COVID-19 and other factors on the usage status of the biologic drug therapies for rheumatoid arthritis: A study from Vietnam Hai-Binh Bui; Hong-Thinh Lai; Thanh-Lam Nguyen; Thuy-Duong Vu; Nhat-Le Bui; Van-Hung Nguyen; Thi-To-Chau Tran; Thi-Phuong-Thuy Nguyen; Thi-Ngoc-Lan Nguyen; Jaffar A. Al-Tawfiq; Dinh-Toi Chu;

Clinical course and flare predictors in patients with rheumatoid arthritis in low disease activity and ultrasound remission monitored by ultrasound yearly and on-demand: A prospective 2-year observation study Takeo Abe; Masao Tamura; Kazuyuki Tsuboi; Yuko Minagawa; Kazuteru Noguchi; Chie Ogita; Teppei Hashimoto; Naoto Azuma; Kiyoshi Matsui;